Fintel reports that on September 19, 2024, UBS initiated coverage of Exelixis (NasdaqGS:EXEL) with a Neutral recommendation. Analyst Price Forecast Suggests 4.25% Upside As of August 26, 2024, the ...
Some results have been hidden because they may be inaccessible to you